Lensch V, Gabba A, Hincapie R, et al. Carbohydrate-Lectin Interactions Reprogram Dendritic Cells to Promote Type 1 Anti-Tumor Immunity. ACS nano. 2024. doi:10.1021/acsnano.4c07360
Wu B, Koehler AN, Westcott PMK. New opportunities to overcome T cell dysfunction: the role of transcription factors and how to target them. Trends in biochemical sciences. 2024. doi:10.1016/j.tibs.2024.08.002
Luo Z, Mei J, Wang X, et al. Voluntary exercise sensitizes cancer immunotherapy via the collagen inhibition-orchestrated inflammatory tumor immune microenvironment. Cell reports. 2024;43(9):114697. doi:10.1016/j.celrep.2024.114697
Cui C, Ott PA, Wu CJ. Advances in Vaccines for Melanoma. Hematology/oncology clinics of North America. 2024. doi:10.1016/j.hoc.2024.05.009
Pires IS, Covarrubias G, Gomerdinger VF, et al. "Target-and-release" nanoparticles for effective immunotherapy of metastatic ovarian cancer. bioRxiv : the preprint server for biology. 2024. doi:10.1101/2024.07.05.602135
Sol S, Boncimino F, Todorova K, Waszyn SE, Mandinova A. Therapeutic Approaches for Non-Melanoma Skin Cancer: Standard of Care and Emerging Modalities. International journal of molecular sciences. 2024;25(13). doi:10.3390/ijms25137056
Di Federico A, Alden SL, Smithy JW, et al. Intrapatient variation in PD-L1 expression and tumor mutational burden and the impact on outcomes to immune checkpoint inhibitor therapy in patients with non-small cell lung cancer. Annals of oncology : official journal of the European Society for Medical Oncology. 2024. doi:10.1016/j.annonc.2024.06.014
Foda BM, Misek SA, Gallo KA, Neubig RR. Inhibition of the Rho/MRTF pathway improves the response of BRAF-resistant melanoma to PD1/PDL1 blockade. International journal of cancer. 2024. doi:10.1002/ijc.35056
Zhivaki D, Kennedy SN, Park J, et al. Correction of age-associated defects in dendritic cells enables CD4 TÂ cells to eradicate tumors. Cell. 2024. doi:10.1016/j.cell.2024.05.026
Zarif TE, Semaan K, Eid M, et al. Epigenomic signatures of sarcomatoid differentiation to guide the treatment of renal cell carcinoma. Cell reports. 2024;43(6):114350. doi:10.1016/j.celrep.2024.114350